Cite this answer
Argireline: quick citable summary
Argireline is listed by PeptaHub as a skin & beauty peptide with a unregulated legal-status classification. The page summarizes mechanism, research context, common routes, safety notes, and references for writers and AI answer engines.
PeptaHub. “Argireline: Mechanism, Research Context, Safety.” peptahub.com, 2026. https://peptahub.com/peptides/argireline. Licensed CC BY 4.0.
License: Creative Commons Attribution 4.0 International. Link back to https://peptahub.com/peptides/argireline.
What is Argireline?
Argireline (Acetyl Hexapeptide-8) is a topical cosmetic peptide that reduces expression wrinkles by interfering with SNARE complex formation. A 10 percent emulsion reduced wrinkle depth by up to 30 percent over 30 days, and a 60-subject randomised trial found benefit over placebo at 4 weeks.
Overview
Argireline (Acetyl Hexapeptide-8) is a synthetic hexapeptide used topically to reduce the appearance of expression lines and wrinkles. It is a fragment of SNAP-25, a protein involved in neurotransmitter vesicle docking, and is marketed as a topical alternative to botulinum toxin injections. It is one of the most studied cosmetic signal peptides.
Mechanism of action
Argireline competitively inhibits the formation of the SNARE complex — the protein assembly responsible for synaptic vesicle fusion and acetylcholine release at the neuromuscular junction. By mimicking the N-terminal portion of SNAP-25, it interferes with catecholamine secretion and reduces repetitive facial muscle contractions that cause dynamic wrinkles. Unlike botulinum toxin, which cleaves SNAP-25 irreversibly, Argireline's inhibition is reversible and topically limited, with no systemic neuromuscular blockade observed at cosmetic concentrations.
Reported study ranges
| Purpose | Route | Reported range | Frequency | Notes |
|---|---|---|---|---|
| wrinkle reduction | topical | 5–10 % | twice daily | Apply to clean, dry skin. The published human studies used a 10 percent emulsion for 30 days and twice-daily application for 4 weeks. Lower concentrations are common in commercial serums but have not been tested in a published trial. |
Reported ranges are for research context only. Consult a qualified healthcare professional before using any peptide.
Convert Argireline research-range units
Need to convert mg to mcg, dose volume, or U-100 syringe units? Use the peptide dose unit converter for educational calculation support.
Research summary
Two human studies underpin the anti-wrinkle claim, and neither reports the figures usually quoted for Argireline. Blanes-Mira (Int J Cosmet Sci 2002) applied a 10 percent oil-in-water emulsion to healthy women volunteers and reported wrinkle depth reduced by up to 30 percent after 30 days; that arm was not placebo-controlled. Wang (Am J Clin Dermatol 2013) randomised 60 Chinese subjects 3:1 to argireline or placebo for peri-orbital wrinkles over 4 weeks and reported total anti-wrinkle efficacy of 48.9 percent on subjective assessment versus 0 percent for placebo, with roughness parameters decreased on silicone-replica analysis. Blanes-Mira also reported no oral toxicity and no primary irritation at high doses in vivo. No published human study has measured systemic absorption of Argireline, so its absence is untested rather than demonstrated.[1][2][3][4][5]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Argireline for synergistic effects.
Legal status
Approved for use as a cosmetic ingredient in the US, EU, and most global markets. Regulated as a cosmetic, not a drug, provided no therapeutic claims are made. No prescription required. Available in over-the-counter serums and creams.
Sourcing & access
Research compound
Argireline is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
Argireline (Acetyl Hexapeptide-8) is a synthetic cosmetic peptide that reduces expression lines and wrinkles when applied topically. It works by interfering with the SNARE protein complex that enables muscle contraction, similar in concept to botulinum toxin but far less potent and fully reversible.
Argireline works through a related mechanism but is far less potent. Botulinum toxin irreversibly cleaves SNAP-25; Argireline interferes with formation of the SNARE complex and inhibited neurotransmitter release with a potency similar to botulinum toxin A but much lower efficacy in the original characterisation. The human results are modest by comparison: up to 30 percent wrinkle depth reduction after 30 days of a 10 percent emulsion, and 48.9 percent subjective anti-wrinkle efficacy versus 0 percent placebo in a 60-subject 4-week trial. No head-to-head study against injectable botulinum toxin exists.
The published trials ran 30 days at 10 percent (Blanes-Mira 2002) and 4 weeks twice daily (Wang 2013), so effects within roughly a month are what the evidence supports. No published study has tested what happens after discontinuation, so claims about how quickly wrinkle depth rebounds are unsourced.
The original characterisation reported no oral toxicity and no primary irritation at high doses in vivo (Blanes-Mira 2002), and a later cell-culture study examined its cytotoxicity (Grosicki 2014). Reported side effects in use are limited to mild skin irritation or redness at the application site. No published human study has measured systemic absorption or neurological endpoints, so the absence of those effects is untested rather than demonstrated. It is regulated as a cosmetic rather than a drug.
Argireline is commonly combined with Matrixyl for structural collagen support, GHK-Cu for tissue remodeling, SYN-AKE for additional expression line reduction through a different neuromuscular pathway, and Palmitoyl Tetrapeptide-7 for anti-inflammatory effects. These multi-peptide serums target both dynamic and static wrinkles through complementary mechanisms across SNARE inhibition, matrix remodeling, and inflammation control.
Research references
- A synthetic hexapeptide (Argireline) with antiwrinkle activityPubMed
- The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled studyPubMed
- The study of cellular cytotoxicity of argireline - an anti-aging peptidePubMed
- Argireline: Needle-Free Botox as Analytical ChallengePubMed
- Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia® Complexion Analysis camera system for objective skin analysisPubMed